A Pharmacokinetics (PK) and Safety Study to Determine the Effect of Repeat Dosing of Trametinib on Combined Oral Contraceptive (Norethindrone Plus Ethinyl Estradiol) in Female Subjects With Solid Tumors

Name: A Pharmacokinetics (PK) and Safety Study to Determine the Effect of Repeat Dosing of Trametinib on Combined Oral Contraceptive (Norethindrone Plus Ethinyl Estradiol) in Female Subjects With Solid Tumors
Published: 2016
License: Public Domain

GlaxoSmithKline · 2016

ClinicalTrials.gov · Datasets · License: Public Domain · 2016

Open Source ↗

cancer pharmacokinetics safety

cancer, pharmacokinetics, solid tumors, safety, trametinib, mek inhibitor, combined oral contraceptive, trametinib's metabolite m5, norethindrone, ethinyl estradiol, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Pharmacokinetics (PK) and Safety Study to Determine the Effect of Repeat Dosing of Trametinib on Combined Oral Contraceptive (Norethindrone Plus Ethinyl Estradiol) in Female Subjects With Solid Tumors

Related documents